Determinants of substrate recognition by the Escherichia coli multidrug transporter MdfA identified on both sides of the membrane

被引:54
作者
Adler, J [1 ]
Bibi, E [1 ]
机构
[1] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel
关键词
D O I
10.1074/jbc.M313422200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Escherichia coli multidrug transporter MdfA contains a membrane-embedded charged residue (Glu-26) that was shown to play an important role in substrate recognition. To identify additional determinants of multidrug recognition we isolated 58 intragenic second-site mutations that restored the function of inactive MdfA E26X mutants. In addition, two single-site mutations that enhanced the activity of wild-type MdfA were identified. Most of the mutations were found in two regions, the cytoplasmic half of transmembrane segments (TMs) 4, 5, and 6 (cluster 1) and the periplasmic half of TM 1 and 2 ( cluster 2). The identified residues were mutated to cysteines in the background of a functional cysteineless MdfA, and substrate protection against alkylation was analyzed. The results support the suggestion that the two clusters are involved in substrate recognition. Using inverted membrane vesicles we observed that a proton electrochemical gradient (Delta(mu) over tilde (H+), inside positive and acidic) enhanced the substrate-protective effect in the cytoplasmic region, whereas it largely reduced this effect in the periplasmic side of MdfA. Therefore, we propose that substrates interact with two sites in MdfA, one in the cytoplasmic leaflet of the membrane and the other in the periplasmic leaflet. Theoretically, these domains could constitute a large part of the multidrug pathway through MdfA.
引用
收藏
页码:8957 / 8965
页数:9
相关论文
共 44 条
[21]   The Escherichia coli multidrug transporter MdfA catalyzes both electrogenic and electroneutral transport reactions [J].
Lewinson, O ;
Adler, J ;
Poelarends, GJ ;
Mazurkiewicz, P ;
Driessen, AJM ;
Bibi, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1667-1672
[22]   Evidence for simultaneous binding of dissimilar substrates by the Escherichia coli multidrug transporter MdfA [J].
Lewinson, O ;
Bibi, E .
BIOCHEMISTRY, 2001, 40 (42) :12612-12618
[23]   Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein [J].
Loo, TW ;
Clarke, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (46) :44332-44338
[24]   Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil [J].
Loo, TW ;
Clarke, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14972-14979
[25]   Identification of residues within the drug-binding domain of the human multidrug resistance P-glycoprotein by cysteine-scanning mutagenesis and reaction with dibromobimane [J].
Loo, TW ;
Clarke, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) :39272-39278
[26]   Evidence for chloramphenicol/H+ antiport in Cmr (MdfA) system of Escherichia coli and properties of the antiporter [J].
Mine, T ;
Morita, Y ;
Kataoka, A ;
Mizushima, T ;
Tsuchiya, T .
JOURNAL OF BIOCHEMISTRY, 1998, 124 (01) :187-193
[27]   Scanning cysteine accessibility of EmrE, an H+-coupled multidrug transporter from Escherichia coli, reveals a hydrophobic pathway for solutes [J].
Mordoch, SS ;
Granot, D ;
Lebendiker, M ;
Schuldiner, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :19480-19486
[28]   Crystal structure of bacterial multidrug efflux transporter AcrB [J].
Murakami, S ;
Nakashima, R ;
Yamashita, E ;
Yamaguchi, A .
NATURE, 2002, 419 (6907) :587-593
[29]   Multiple antibiotic resistance and efflux [J].
Nikaido, H .
CURRENT OPINION IN MICROBIOLOGY, 1998, 1 (05) :516-523
[30]   Isolation of cmr, a novel Escherichia coli chloramphenicol resistance gene encoding a putative efflux pump [J].
Nilsen, IW ;
Bakke, I ;
Vader, A ;
Olsvik, O ;
ElGewely, MR .
JOURNAL OF BACTERIOLOGY, 1996, 178 (11) :3188-3193